Giorgio CASABURI, PhD, MSc

Exagen Inc.
San Marcos, CA, United States

Director of Bioinformatics leading a team of bioinformatics scientists and DevOps engineers. My unique combination of experiences, from the laboratory to the supercomputer as well as IP and regulatory affairs in the startup environment, have given me a broad understanding of biomedical research and corporate strategies in the era of Big Data biology.

Summary:
• Passionate about meta-omics big data, especially in the context of the microbiome
• Proven track record of translational applications from data to clinical interventions and diagnostic
• +10 years of experience in data analysis for life sciences (genomics, transcriptomics, metaomics)
• Published +40 papers in peer-reviewed international journals and 1 academic book
• Inventors on 3 patents and 3 bioinformatics software
• Presented original research at +30 international conferences
• Presented data, analysis and business plans to executives, investors, and VC during fundraising

Disclosure information not submitted.

Presentation(s):

0935: Targeted Synovial Tissue RNA-Seq Coupled with Artificial Intelligence Accurately Predicts Early Rheumatoid Arthritis Patients Likely to Respond to CsDMARDs, Enriching CsDMARDs Response Rates and Enabling Early Identification of Patients Requiring Subsequent Biological Therapy
Sunday, November 13, 2022
9:00 AM – 10:30 AM Eastern Time
0935: Targeted Synovial Tissue RNA-Seq Coupled with Artificial Intelligence Accurately Predicts Early Rheumatoid Arthritis Patients Likely to Respond to CsDMARDs, Enriching CsDMARDs Response Rates and Enabling Early Identification of Patients Requiring Subsequent Biological Therapy
Monday, November 14, 2022
1:45 PM – 1:50 PM Eastern Time
1990: Artificial Intelligence Applied to Transcriptomics Profiling of Synovial Tissue Biopsies Accurately Predicts Rheumatoid Arthritis Patients Who Will Respond or Be Refractory to Standard Biological Treatments
Monday, November 14, 2022
1:00 PM – 3:00 PM Eastern Time